A Retrospective Cohort Study of Racial/Ethnic and Socioeconomic Disparities in Initiation and Meaningful Use of Continuous Glucose Monitoring Among Youth With Type 1 Diabetes.

BACKGROUND

Continuous glucose monitor (CGM) use improves type 1 diabetes (T1D) outcomes, yet children from diverse backgrounds and on public insurance have worse outcomes and lower CGM utilization. Using novel CGM data acquisition and analysis of two T1D cohorts, we test the hypothesis that T1D youth from different backgrounds experience disparities in meaningful CGM use following both T1D diagnosis and CGM uptake.

METHODS

Cohorts drawn from a pediatric T1D program were followed for one year beginning at diagnosis ( = 815, 2016-2020) or CGM uptake ( = 1392, 2015-2020). Using chart and CGM data, CGM start and meaningful use outcomes between racial/ethnic and insurance groups were compared using median days, one-year proportions, and survival analysis.

RESULTS

Publicly compared with privately insured were slower to start CGM (233, 151 days, < .01), had fewer use-days in the year following uptake (232, 324, < .001), and had faster first discontinuation rates (hazard ratio [HR] = 1.61, < .001). Disparities were more pronounced among Hispanic and black compared with white subjects for CGM start time (312, 289, 149, = .0013) and discontinuation rates (Hispanic HR = 2.17, < .001; black HR = 1.45, = .038), and remained even among privately insured (Hispanic/black HR = 1.44, = .0286).

CONCLUSIONS

Given the impact of insurance and race/ethnicity on CGM initiation and use, it is imperative that we target interventions to support universal access and sustained CGM use to mitigate the potential impact of provider biases and systemic disadvantage and racism. By enabling more equitable and meaningful T1D technology use, such interventions will begin to alleviate outcome disparities between youth with T1D from different backgrounds.